H1N1, but not H3N2, influenza a virus infection protects ferrets from H5N1 encephalitis

Journal of Virology

Volumn 88, Issue 6, 2014, Pages 3077-3091

  Bissel, Stephanie J ^a   Wang, Guoji ^a   Carter, Donald M ^b   Crevar, Corey J ^b   Ross, Ted M ^a,b   Wiley, Clayton A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VIRUS HEMAGGLUTININ;

2009 H1N1 INFLUENZA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVIAN INFLUENZA VIRUS; BRAIN; BRONCHITIS; CONTROLLED STUDY; CROSS PROTECTION; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; FEMALE; FERRET; HEPATITIS; IMMUNITY; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLUENZA A (H3N2); INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; LAMINA PROPRIA; LIVER; LUNG INFECTION; MORTALITY; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SMALL INTESTINE; SPLEEN; SYSTEMIC DISEASE; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS ENCEPHALITIS; VIRUS ISOLATION; VIRUS RECOMBINATION; VIRUS REPLICATION; VIRUS STRAIN; ZOONOSIS;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; ENCEPHALITIS; FEMALE; FERRETS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN;

EID: 84894548161     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01840-13     Document Type: Article

References (70)

1. Claas EC, Osterhaus AD, van Beek R, De Jong JC, Rimmelzwaan GF, Senne DA, Krauss S, Shortridge KF, Webster RG. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477. http://dx.doi.org/10.1016/S0140-6736(97)11212-0.
2. Domínguez-Cherit G, Namendys-Silva SA, de la Torre A, Macias AE, Cordova-Villalobos JA. 2010. H1N1 influenza pandemic of 2009 compared with other influenza pandemics: epidemiology, diagnosis, management, pulmonary complications, and outcomes. Curr. Infect. Dis. Rep. 12:204-210. http://dx.doi.org/10.1007/s11908-010-0097-0.
3. Morens DM, Taubenberger JK, Fauci AS. 2009. The persistent legacy of the 1918 influenza virus. N. Engl. J. Med. 361:225-229. http://dx.doi.org/10.1056/NEJMp0904819.
4. Zimmer SM, Burke DS. 2009. Historical perspective-emergence of influenza A (H1N1) viruses. N. Engl. J. Med. 361:279-285. http://dx.doi.org/10.1056/NEJMra0904322.
5. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. 2009. Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122-1125. http://dx.doi.org/10.1038/nature08182.
6. Medina RA, Garcia-Sastre A. 2011. Influenza A viruses: new research developments. Nat. Rev. Microbiol. 9:590-603. http://dx.doi.org/10.1038/nrmicro2613.
7. Watanabe Y, Ibrahim MS, Suzuki Y, Ikuta K. 2012. The changing nature of avian influenza A virus (H5N1). Trends Microbiol. 20:11-20. http://dx.doi.org/10.1016/j.tim.2011.10.003.
8. de Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL. 1997. A pandemic warning? Nature 389:554. http://dx.doi.org/10.1038/39221, 10.1038/39218.
9. Subbarao K, Klimov A, Katz J, Regnery H, Lim W, Hall H, Perdue M, Swayne D, Bender C, Huang J, Hemphill M, Rowe T, Shaw M, Xu X, Fukuda K, Cox N. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396. http://dx.doi.org/10.1126/science.279.5349.393.
10. Ungchusak K, Auewarakul P, Dowell SF, Kitphati R, Auwanit W, Puthavathana P, Uiprasertkul M, Boonnak K, Pittayawonganon C, Cox NJ, Zaki SR, Thawatsupha P, Chittaganpitch M, Khontong R, Simmerman JM, Chunsutthiwat S. 2005. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352:333-340. http://dx.doi.org/10.1056/NEJMoa044021.
11. Wang H, Feng Z, Shu Y, Yu H, Zhou L, Zu R, Huai Y, Dong J, Bao C, Wen L, Wang H, Yang P, Zhao W, Dong L, Zhou M, Liao Q, Yang H, Wang M, Lu X, Shi Z, Wang W, Gu L, Zhu F, Li Q, Yin W, Yang W, Li D, Uyeki TM, Wang Y. 2008. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet 371:1427-1434. http://dx.doi.org/10.1016/S0140-6736(08)60493-6.
12. WHO/PED. 2013. Cumulative number of confirmed human cases for avian influenza A (H5N1) reported to WHO, 2003-2013. World Health Organization, Geneva, Switzerland. http://www.who.int/influenza/huma n_animal_interface/EN_GIP_20130201CumulativeNumberH5N1cases. pdf.
13. Spesock A, Malur M, Hossain MJ, Chen LM, Njaa BL, Davis CT, Lipatov AS, York IA, Krug RM, Donis RO. 2011. The virulence of 1997 H5N1 influenza viruses in the mouse model is increased by correcting a defect in their NS1 proteins. J. Virol. 85:7048-7058. http://dx.doi.org/10.1128/JVI.00417-11.
14. Kuiken T, van den Brand J, van Riel D, Pantin-Jackwood M, Swayne DE. 2010. Comparative pathology of select agent influenzaAvirus infections. Vet. Pathol. 47:893-914. http://dx.doi.org/10.1177/0300985810378651.
15. Cardona CJ, Xing Z, Sandrock CE, Davis CE. 2009. Avian influenza in birds and mammals. Comp. Immunol. Microbiol. Infect. Dis. 32:255-273. http://dx.doi.org/10.1016/j.cimid.2008.01.001.
16. Bodewes R, Kreijtz JH, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF, Kuiken T. 2011. Pathogenesis of influenza A/H5N1 virus infection in ferrets differs between intranasal and intratracheal routes of inoculation. Am. J. Pathol. 179:30-36. http://dx.doi.org/10.1016/j.ajpath.2011.03.026.
17. Lipatov AS, Kwon YK, Pantin-Jackwood MJ, Swayne DE. 2009. Pathogenesis of H5N1 influenza virus infections in mice and ferret models differs according to respiratory tract or digestive system exposure. J. Infect. Dis. 199:717-725. http://dx.doi.org/10.1086/596740.
18. Gustin KM, Belser JA, Wadford DA, Pearce MB, Katz JM, Tumpey TM, Maines TR. 2011. Influenza virus aerosol exposure and analytical system for ferrets. Proc. Natl. Acad. Sci. U.S.A. 108:8432-8437. http://dx.doi.org/10.1073/pnas.1100768108.
19. Lednicky JA, Hamilton SB, Tuttle RS, Sosna WA, Daniels DE, Swayne DE. 2010. Ferrets develop fatal influenza after inhaling small particle aerosols of highly pathogenic avian influenza virus A/Vietnam/1203/2004 (H5N1). Virol. J. 7:231. http://dx.doi.org/10.1186/1743-422X-7-231.
20. Nishimura H, Itamura S, Iwasaki T, Kurata T, Tashiro M. 2000. Characterization of human influenza A (H5N1) virus infection in mice: neuro-, pneumo-and adipotropic infection. J. Gen. Virol. 81:2503-2510. http://vir.sgmjournals.org/content/81/10/2503.long.
21. Garigliany MM, Habyarimana A, Lambrecht B, Van de Paar E, Cornet A, van den Berg T, Desmecht D. 2010. Influenza A strain-dependent pathogenesis in fatal H1N1 and H5N1 subtype infections of mice. Emerg. Infect. Dis. 16:595-603. http://dx.doi.org/10.3201/eid1604.091061.
22. Rimmelzwaan GF, Kuiken T, van Amerongen G, Bestebroer TM, Fouchier RA, Osterhaus AD. 2001. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol. 75:6687-6691. http://dx.doi.org/10.1128/JVI.75.14.6687-6691.2001.
23. Giles BM, Crevar CJ, Carter DM, Bissel SJ, Schultz-Cherry S, Wiley CA, Ross TM. 2012. A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. J. Infect. Dis. 205:1562-1570. http://dx.doi.org/10.1093/infdis/jis232.
24. Maher JA, DeStefano J. 2004. The ferret: an animal model to study influenza virus. Lab Anim. 33:50-53. http://dx.doi.org/10.1038/laban1004-50.
25. Belser JA, Katz JM, Tumpey TM. 2011. The ferret as a model organism to study influenza A virus infection. Dis. Model Mech. 4:575-579. http://dx.doi.org/10.1242/dmm.007823.
26. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. 2012. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 336:1534-1541. http://dx.doi.org/10.1126/science.1213362.
27. van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T. 2007. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol. 171:1215-1223. http://dx.doi.org/10.2353/ajpath.2007.070248.
28. Bodewes R, Kreijtz JH, Geelhoed-Mieras MM, van Amerongen G, Verburgh RJ, van Trierum SE, Kuiken T, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2011. Vaccination against seasonal influenza A/H3N2 virus reduces the induction of heterosubtypic immunity against influenza A/H5N1 virus infection in ferrets. J. Virol. 85:2695-2702. http://dx.doi.org/10.1128/JVI.02371-10.
29. Lewington JH. 2000. Ferret husbandry, medicine, and surgery. Butterworth-Heinemann, Oxford, United Kingdom.
30. Fox JG. 1998. Biology and diseases of the ferret, 2nd ed. Williams & Wilkins, Baltimore, MD.
31. National Research Council. 2011. Guide for the care and use of laboratory animals, 8th ed. National Academies Press, Washington, DC.
32. U.S. Department of Health and Human Services. 2009. Biosafety in microbiological and biomedical laboratories, 5th ed. Department of Health and Human Services, Washington, DC.
33. Tobita K. 1975. Permanent canine kidney (MDCK) cells for isolation and plaque assay of influenza B viruses. Med. Microbiol. Immunol. 162:23-27. http://dx.doi.org/10.1007/BF02123574.
34. Tobita K, Sugiura A, Enomote C, Furuyama M. 1975. Plaque assay and primary isolation of influenza A viruses in an established line of canine kidney cells (MDCK) in the presence of trypsin. Med. Microbiol. Immunol. 162:9-14. http://dx.doi.org/10.1007/BF02123572.
35. Giles BM, Bissel SJ, Craigo JK, Dealmeida DR, Wiley CA, Tumpey TM, Ross TM. 2012. Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice. J. Virol. 86:1500-1513. http://dx.doi.org/10.1128/JVI.06034-11.
36. Krammer F, Pica N, Hai R, Margine I, Palese P. 2013. Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies. J. Virol. 87:6542-6550. http://dx.doi.org/10.1128/JVI.00641-13.
37. Bissel SJ, Wang G, Ghosh M, Reinhart TA, Capuano S, III, Stefano Cole K, Murphey-Corb M, Piatak M, Jr, Lifson JD, Wiley CA. 2002. Macrophages relate presynaptic and postsynaptic damage in simian immunodeficiency virus encephalitis. Am. J. Pathol. 160:927-941. http://dx.doi.org/10.1016/S0002-9440(10)64915-2.
38. Johnson JK, Berman NE. 1996. A transient phase of cell death in the developing medial forebrain of the perinatal ferret. Brain Res. Dev. Brain Res. 94:159-165. http://dx.doi.org/10.1016/S0165-3806(96)80007-1.
39. Fallert BA, Reinhart TA. 2002. Improved detection of simian immunodeficiency virus RNA by in situ hybridization in fixed tissue sections: combined effects of temperatures for tissue fixation and probe hybridization. J. Virol. Methods 99:23-32. http://dx.doi.org/10.1016/S0166-0934(01)00378-0.
40. Bissel SJ, Giles BM, Wang G, Olevian DC, Ross TM, Wiley CA. 2012. Acute murine H5N1 influenza A encephalitis. Brain Pathol. 22:150-158. http://dx.doi.org/10.1111/j.1750-3639.2011.00514.x.
41. Wang X, Zhao J, Tang S, Ye Z, Hewlett I. 2010. Viremia associated with fatal outcomes in ferrets infected with avian H5N1 influenza virus. PLoS One 5:e12099. http://dx.doi.org/10.1371/journal.pone.0012099.
42. Nakata M, Itou T, Sakai T. 2009. Quantitative analysis of inflammatory cytokines expression in peripheral blood mononuclear cells of the ferret (Mustela putorius furo) using real-time PCR. Vet. Immunol. Immunopathol. 130:88-91. http://dx.doi.org/10.1016/j.vetimm.2008.12.009.
43. Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. 2008. Human infection with highly pathogenic H5N1 influenza virus. Lancet 371:1464-1475. http://dx.doi.org/10.1016/S0140-6736(08)60627-3.
44. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, Lau LT, Lu J, Zhang B, McNutt MA, Lu M, Anderson VM, Gong E, Yu AC, Lipkin WI. 2007. H5N1 infection of the respiratory tract and beyond: a molecular pathology study. Lancet 370:1137-1145. http://dx.doi.org/10.1016/S0140-6736(07)61515-3.
45. Beigel JH, Farrar J, Han AM, Hayden FG, Hyer R, de Jong MD, Lochindarat S, Nguyen TK, Nguyen TH, Tran TH, Nicoll A, Touch S, Yuen KY, Writing Committee of the World Health Organization Consultation on Human Influenza A/H5. 2005. Avian influenza A (H5N1) infection in humans. N. Engl. J. Med. 353:1374-1385. http://dx.doi.org/10.1056/NEJMra052211.
46. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K, Peiris M, Nicholls JM, Chokephaibulkit K, Vanprapar N, Auewarakul P. 2005. Influenza A H5N1 replication sites in humans. Emerg. Infect. Dis. 11:1036-1041. http://dx.doi.org/10.3201/eid1107.041313.
47. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, Qui PT, Cam BV, Ha do Q, Guan Y, Peiris JS, Chinh NT, Hien TT, Farrar J. 2006. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med. 12:1203-1207. http://dx.doi.org/10.1038/nm1477.
48. Maines TR, Jayaraman A, Belser JA, Wadford DA, Pappas C, Zeng H, Gustin KM, Pearce MB, Viswanathan K, Shriver ZH, Raman R, Cox NJ, Sasisekharan R, Katz JM, Tumpey TM. 2009. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science 325:484-487. http://dx.doi.org/10.1126/science.1177238.
49. Rowe T, Leon AJ, Crevar CJ, Carter DM, Xu L, Ran L, Fang Y, Cameron CM, Cameron MJ, Banner D, Ng DC, Ran R, Weirback HK, Wiley CA, Kelvin DJ, Ross TM. 2010. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 401:257-265. http://dx.doi.org/10.1016/j.virol.2010.02.020.
50. Smith H, Sweet C. 1988. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis. 10:56-75. http://dx.doi.org/10.1093/clinids/10.1.56.
51. Belser JA, Szretter KJ, Katz JM, Tumpey TM. 2009. Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. Adv. Virus Res. 73:55-97. http://dx.doi.org/10.1016/S0065-3527(09)73002-7.
52. Huang SS, Banner D, Fang Y, Ng DC, Kanagasabai T, Kelvin DJ, Kelvin AA. 2011. Comparative analyses of pandemic H1N1 and seasonal H1N1, H3N2, and influenza B infections depict distinct clinical pictures in ferrets. PLoS One 6:e27512. http://dx.doi.org/10.1371/journal.pone.0027512.
53. Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA. 2009. Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 325:481-483. http://dx.doi.org/10.1126/science.1177127.
54. Ma W, Kahn RE, Richt JA. 2009. The pig as a mixing vessel for influenza viruses: human and veterinary implications. J. Mol. Genet. Med. 3:158-166. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2702078/.
55. Scholtissek C, Burger H, Kistner O, Shortridge KF. 1985. The nucleoprotein as a possible major factor in determining host specificity of influenza H3N2 viruses. Virology 147:287-294. http://dx.doi.org/10.1016/0042-6822(85)90131-X.
56. Ma W, Lager KM, Vincent AL, Janke BH, Gramer MR, Richt JA. 2009. The role of swine in the generation of novel influenza viruses. Zoonoses Public Health 56:326-337. http://dx.doi.org/10.1111/j.1863-2378.2008.01217.x.
57. Khiabanian H, Trifonov V, Rabadan R. 2009. Reassortment patterns in swine influenza viruses. PLoS Curr. 1:RRN1008. http://dx.doi.org/10.1371/currents.RRN1008.
58. Cline TD, Karlsson EA, Seufzer BJ, Schultz-Cherry S. 2013. The hemagglutinin protein of highly pathogenic H5N1 influenza viruses overcomes an early block in the replication cycle to promote productive replication in macrophages. J. Virol. 87:1411-1419. http://dx.doi.org/10.1128/JVI.02682-12.
59. Kreijtz JH, Bodewes R, van den Brand JM, de Mutsert G, Baas C, van Amerongen G, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2009. Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus. Vaccine 27:4983-4989. http://dx.doi.org/10.1016/j.vaccine.2009.05.079.
60. Hammerbeck DM, Burleson GR, Schuller CJ, Vasilakos JP, Tomai M, Egging E, Cochran FR, Woulfe S, Miller RL. 2007. Administration of a dual toll-like receptor 7 and toll-like receptor 8 agonist protects against influenza in rats. Antiviral Res. 73:1-11. http://dx.doi.org/10.1016/j.antiviral.2006.07.011.
61. Yager EJ, Szaba FM, Kummer LW, Lanzer KG, Burkum CE, Smiley ST, Blackman MA. 2009. γ-Herpesvirus-induced protection against bacterial infection is transient. Viral Immunol. 22:67-72. http://dx.doi.org/10.1089/vim.2008.0086.
62. Abe T, Takahashi H, Hamazaki H, Miyano-Kurosaki N, Matsuura Y, Takaku H. 2003. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J. Immunol. 171:1133-1139. http://www.jimmunol.org/content/171/3/1133.long.
63. Russell RJ, Kerry PS, Stevens DJ, Steinhauer DA, Martin SR, Gamblin SJ, Skehel JJ. 2008. Structure of influenza hemagglutinin in complex with an inhibitor of membrane fusion. Proc. Natl. Acad. Sci. U.S.A. 105: 17736-17741. http://dx.doi.org/10.1073/pnas.0807142105.
64. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. 2007. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med. 4:e59. http://dx.doi.org/10.1371/journal.pmed.0040059.
65. Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, Bodle J, Pearse M, Middleton D. 2013. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. J. Virol. 87:3053-3061. http://dx.doi.org/10.1128/JVI.02434-12.
66. Van Kerkhove MD, Mumford E, Mounts AW, Bresee J, Ly S, Bridges CB, Otte J. 2011. Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PLoS One 6:e14582. http://dx.doi.org/10.1371/journal.pone.0014582.
67. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. 2012. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature 486:420-428. http://dx.doi.org/10.1038/nature10831.
68. Bridges CB, Lim W, Hu-Primmer J, Sims L, Fukuda K, Mak KH, Rowe T, Thompson WW, Conn L, Lu X, Cox NJ, Katz JM. 2002. Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998. J. Infect. Dis. 185:1005-1010. http://dx.doi.org/10.1086/340044.
69. Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, van den Brand JM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2009. Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus. PLoS One 4:e5538. http://dx.doi.org/10.1371/journal.pone.0005538.
70. Bodewes R, Fraaij PL, Kreijtz JH, Geelhoed-Mieras MM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF. 2012. Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 30:7407-7410. http://dx.doi.org/10.1016/j.vaccine.2012.04.086.